Consolidated Statements of Convertible Preferred Stock and Stockholders' Equity (Deficit) - USD ($)	Total	Common Stock [Member]	Additional Paid-in Capital [Member]	Accumulated Deficit [Member]	Noncontrolling Interest [Member]	Series E Convertible Preferred Stock [Member]	Series E Convertible Preferred Stock [Member] Preferred Stock [Member]	Common Class B [Member]
Beginning Balance at Dec. 31, 2019							$ 133,484,531
Beginning Balance (Share) at Dec. 31, 2019						27,011,500
Beginning Balance at Dec. 31, 2019	$ (106,917,585)	$ 96,427	$ 28,443,614	$ (129,606,619)	$ (5,851,007)
Beginning Balance (Share) at Dec. 31, 2019		9,642,705
Exercise of common stock warrants	22,221,173	$ 43,370	22,177,803
Exercise of common stock warrants (in Shares)		4,336,970
Exercise of stock options	850,681	$ 8,054	842,627
Exercise of stock options (in Shares)		805,450
Repurchase of common stock		$ (24,613)	24,613
Repurchase of common stock (in Shares)		(2,461,295)
Stock-based compensation	963,205		963,205
Net income (loss)	(3,953,813)			(3,357,746)	(596,067)
Ending Balance at Dec. 31, 2020						$ 133,484,531
Ending Balance (Share) at Dec. 31, 2020						27,011,500
Ending Balance at Dec. 31, 2020	(86,836,339)	$ 123,238	52,451,862	(132,964,365)	(6,447,074)
Ending Balance (Share) at Dec. 31, 2020		12,323,830
Common stock issued in exchange for remaining interest in consolidated affiliate				(6,447,074)	6,447,074
Common stock issued in exchange for remaining interest in consolidated affiliate (in Shares)								6,179,270
Noncontrolling interest in acquired subsidiary	209,592				209,592
Conversion of all shares of Class B common stock to common stock		$ 61,793	(61,793)
Conversion of all shares of Class B common stock to common stock (in Shares)		6,179,270						(6,179,270)
Conversion of Series E convertible preferred stock to common stock	133,484,531	$ 270,115	133,214,416			$ (133,484,531)
Conversion of Series E convertible preferred stock to common stock (in Shares)		27,011,500				(27,011,500)
Issuance of common stock in September 2021 IPO at $10.00 per share, net of issuance costs of $9,999,748	60,000,252	$ 70,000	59,930,252
Issuance of common stock in September 2021 IPO at $10.00 per share, net of issuance costs of $9,999,748 (in Shares)		7,000,000
Exercise of stock options	75,619	$ 396	75,223
Exercise of stock options (in Shares)		39,614
Stock-based compensation	4,554,024		4,554,024
Net income (loss)	6,844,798			7,253,423	(408,625)
Ending Balance at Dec. 31, 2021	$ 118,332,477	$ 525,542	$ 250,163,984	$ (132,158,016)	$ (199,033)
Ending Balance (Share) at Dec. 31, 2021		52,554,214